Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$11.67M
Expense Ratio	0.85%
PE Ratio	17.12
Shares Out	350,000
Dividend (ttm)	$0.23
Dividend Yield	0.70%
Ex-Dividend Date	Dec 31, 2024
Payout Ratio	12.06%
1-Year Return	-0.55%

Volume	320
Open	33.15
Previous Close	33.28
Day's Range	33.15 - 33.22
52-Week Low	31.08
52-Week High	42.41
Beta	1.06
Holdings	32
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

54.69% of assets

Name	Symbol	Weight
Kestra Medical Technologies, Ltd.	KMTS	5.95%
Tarsus Pharmaceuticals, Inc.	TARS	5.92%
Fastenal Company	FAST	5.87%
Unilever PLC	UL	5.82%
SBA Communications Corporation	SBAC	5.67%
H&R Block, Inc.	HRB	5.44%
Invitation Homes Inc.	INVH	5.04%
Welltower Inc.	WELL	5.02%
HDFC Bank Limited	HDB	5.00%
Essential Utilities, Inc.	WTRG	4.98%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.03888	Jan 2, 2019